Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Study Group: Neuroradiologists (US)(?)

Council Members in this Study Group: 55

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Request a survey with this Study Group







Leading Experts in this Study Group

Marc Hamet, MD, President, Image Guided Therapeutics, LLC.Marc Hamet, MD
President
Image Guided Therapeutics, LLC.

Marc Hamet, MD, is the Director of Vascular and Interventional Radiology at Stamford Hospital in Connecticut. He is also the President at Image Guided Therapeutics, LLC. Dr. Hamet is board certified in Diagnostic and Interventional Radiology and Neuroradiology. His areas of expertise include vertebroplasty,...

GLG NewsSMAnalyses by this Study Group's Leading Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Its all about the spin | 08-21-2008
Author: Marc Hamet, MD, President, Image Guided Therapeutics, LLC.

This article could easily be spun as a victory for stent efficacy.

Difficult, but not imposible, trial to complete | 05-01-2008
Author: GLG Expert Contributor

ACR16 is part of a class of drugs called dopaminergic stabilizers. These drugs modulate the effect of dopamine (a neurotransmitter secreted naturally by the brain). While more effects and interactions related to dopamine are constantly being discovered, it is known that dopamine plays a role in movement...

Mipomersen will make it to market but with limited market share | 05-01-2008
Author: GLG Expert Contributor

Mipomersen (formerly known as ISIS 301012) is a in class of novel therapeutic agents that reduce the production of a protein in the liver that is responsible for cholesterol production. It is though that inhibiting that production on a molecular level would decrease the levels of cholesterol. Mipomersen...

BiTE shows more promise than most but no fianlity yet | 04-28-2008
Author: GLG Expert Contributor

Antibodies are formed by the bodies own immune system to any foreign substances it encounters. Tumors are considered by the body to be foreign at it often requires a genetic mutation for cells to become cancerous. Cancers are able to circumvent these natural antibodies by various means but there is...

Hefty price but promising potential | 04-28-2008
Author: GLG Expert Contributor

Situins are enzymes that regulate predetermined cell death, activity in muscle and fat cells as well as energy expenditure. There are several classes of these enzymes (SIRT 1 through 7). The technology is promising in that it promises to regulate some of the causes of diabetes and obesity rather than...

View All GLG News by members of this Study Group

Most Common Company Types:

  • Academic Medical Center/Hospital or Clinic
  • Office Based Private Practice or Clinic
  • Non-Academic Community Hospital or Clinic
  • Laboratory, Independent
  • Other Freestanding Healthcare Facility

Most Common Job Types:

  • Physician - Attending Physician
  • Physician - Director
  • Director
  • Physician - Division Head
  • President
  • Partner
  • Physician - Department Chair
  • Owner

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics


Generated at 2008-12-03T13:45:45.387